Rotavirus infection: An unrecognised disease in Nepal

Kathmandu University Medical Journal

Volumn 8, Issue 29, 2010, Pages 135-140

  Pun, S B ^a  

^a NEPAL INTERNATIONAL CLINIC   (Nepal)

Author keywords

Challenges and recommendations; Epidemiology; Nepal; Rotavirus

Indexed keywords

ROTAVIRUS VACCINE;

CLINICAL FEATURE; DEHYDRATION; DISEASE SEVERITY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN ROTAVIRUS; INFECTION PREVENTION; INTUSSUSCEPTION; MOLECULAR EPIDEMIOLOGY; NEPAL; NONHUMAN; ORAL REHYDRATION THERAPY; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; ROTAVIRUS INFECTION; VIRUS CLASSIFICATION; VIRUS MORPHOLOGY;

EID: 77953656807     PISSN: 18122027     EISSN: 18122078     Source Type: Journal    
DOI: 10.3126/kumj.v8i1.3236     Document Type: Review

References (37)

1. Bryce J, Boschi -Pinto C, Shibuya K, Black RE. WHO estimates of the cause of death in children. Lancet. 2005; 365: 1147-52.
2. Kapikian AZ. Viral gastroenteritis. JAMA. 1993; 269: 627-30.
3. Cunliffe NA, Nakagomi O. A critical time for rotavirus vaccines: a review. Expert Rev Vaccines. 2005; 4 (4): 521-32.
4. Jain V, Prashar UD, Glass RI, Bhan MK. Epidemiology of rotavirus in India. Indian J pediatr. 2001; 68: 855-62.
5. Rojas AM, Boher Y, Guntinas MJ, Perez Schael I. Homotypic immune response to primary infection with rotavirus serotype G1. J Virol. 1995; 47: 404-9.
6. Rimer HC, Wasserman SS, Flores J, Pichichero ME, Losonsky GA. Rotavirus-specific breast milk antibody in two populations and possible correlates of interference with rhesus rotavirus vaccine seroconversion. J Infec Dis.1992; 165: 826-30.
7. Bass DM, Baylor M, Broome R, Greenberg HB. Molecular basis of age-dependent gastric inactivation of rhesus rotavirus in the mouse. J Clin Invest. 1992; 89: 1741-5.
8. Velazquez FR, Matson DO, Calva JJ, Guerrero L, Marrow AL, Carter-Campbell L, et al. Rotavirus Infections in infants as protection against subsequent infections. N Engl J Med. 1996; 335 (14): 1022-8.
9. Kapikian AZ, Kim HW, Wyatt RG, Cline WL, Arrobio JO, Brandt CD, et al. Human reovirus-like agent as the major pathogen associated with winter gastroenteritis in hospitalized infants and young children. N Engl J Med. 1976; 294: 965-72.
10. Cunliffe NA, Kigore PE, Bresee JS, Luo N, Hart CA, Glass RI. Epidemiology of rotavirus diarrhea in Africa: a review to assess the need for rotavirus immunization. Bull WHO. 1998; 76: 525-37.
11. Estes MK. Rotaviruses and their replication. In: Knipe DM, Howley PM, eds. Fields virology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1747-85.
12. Hung T, Chen G, Wang C, Zingyi C, Tungxin C, Wei Wei Y, et al. Rotavirus-like agent in adult non-bacterial diarrhoea in China. Lancet.1983; 2: 1078-9.
13. Kobayashi N., Naik TN, Kusuhara Y, Krishnan T, Sen A, Bhattacharya SK, et al. Sequence analysis of genes encoding structural and nonstructural proteins of a Human group B rotavirus detected in Calcutta India. J Med Virol. 2001; 64 (4): 583-8.
14. Alam MM, Kobayashi N, Ishino M, Wakuda M, Ahmed MS, Ahmed MU, et al. Genetic analysis of an ADRV-N-like novel rotavirus strain B219 detected in a sporadic case of adult diarrhea in Bangladesh. Arch Virol.2007; 152: 199-208.
15. Greenberg H, Estes M. Rotaviruses: From Pathogenesis to Vaccination. Gastroenterology. 2009; 136: 1939-51.
16. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol. 2005; 15: 29-56.
17. Shif I, Iizuka M, Silberstein I, Mendelson E, Nakagomi O. Rotaviruses belonging to the AU-1 genogroup recovered from Israeli infants with diarrhea. Arch Virol.1994; 138: 357- 64.
18. Ramachandra M, Das BK, Vij A, Kumar R, Bhambal SS, Keshan N, et al. Unusual Diversity of Human Rotavirus G and P Genotypes in India. J Clin Microbiol. 1996; 34: 436-9.
19. Shariff M, Deb M, Singh R. A study of diarrhoea among children in Eastern Nepal with special reference to Rotavirus. Indian J Med Microbiol. 2003; 21 (2): 87-90.
20. Karadag A, Acikgoz ZC, Avci Z, Catal F, Gocer S, Gamberzade S, et al. Childhood diarrhoea in Ankara, Turkey: Epidemiological and clinical features of rotavirus-positive versus rotavirus-negative cases. Scand J Infect Dis.2005; 37: 269-75.
21. Oishi I., Kimura T., Murakami T., Haruki K., Seto Y., Minekawa Y. Funamoto H. (1991) Serial observations of chronic rotavirus infection in an immunodeficient child. Microbiol. Immunol.1991; 35: 953-61.
22. World Health Organization. Rotavirus Vaccines, an update. Wkly Epidemiol Rec.2003; 78: 2-3.
23. Nakagomi O, Cunliffe NA. Rotavirus vaccines: entering a new stage of deployment. Curr Opin Infect Dis. 2007; 20: 501-7.
24. Uchida R, Pandey DV, Sherchand JB, Ahmed K, Yokoo M, Nakagomi T, et al. Molecular Epidemiology of Rotavirus Diarrhea among Children and Adults in Nepal: Detection of G12 strains with P[6] or P[8] and a G11P[25] Strain. J Clin Microbiol. 2006; 44: 3499-505.
25. Pun SB, Nakagomi T, Sherchand JB, Pandey BD, Cuevas LE, Cunliffe NA, et al. Nakagomi O Detection of G12 Human Rotaviruses in Nepal. Emerg Infect Dis. 2007; 13: 482-4.
26. Sherchand JB, Nakagomi O, Dove W, Nakagomi T, Yokoo M, Pandey BD, et al. Molecular Epidemiology of Rotavirus Diarrhea among Children Aged <5 Years in Nepal: Predominance of Emergent G12 Strains during 2 Years. J Infect Dis. 2009; 200: S187.
27. Sherchand JB, Haruki K. Rotavirus Diarrhea in Children and Animal of Urban and Rural Nepal. Journal Nepal Health Research Council. 2004; 2: 5-8.
28. Bresee JS, Hummelman E, Nelson EAS. Glass RI. Rotavirus in Asia: The value of Surveillance for Informing Decisions about the Introduction of New Vaccines. J Infect Dis. 2005; 192: S1-5.
29. Jha N, Singh R, Baral D. Knowledge, attitude and practices of mothers regarding home management of acute diarrhea in Sunsari, Nepal. Nepal Med Coll J. 2006; 8 (1): 27-30.
30. Murphy TV, Garguillo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001; 344: 564-72.
31. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate F, Breuer T, Clemens SC et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med.2006; 354: 11-22.
32. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med.2006; 354: 23-33.
33. Steele AD, De Vos B, Tumbo J, Reynders J, Scholtz F, Bos P, et al. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and Polio vaccines. Vaccine. 2008; doi: 10.1016/j.vaccine.2008.08.034
34. Zaman K, Sack DA, Yunus M, Arifeen SE, Podder G, Azim T, Luby S, Breiman RF, Neuzil K, Datta SK, Delem A, Suryakiran PV, Block HL, and the Bangladeshi Rotavirus Vaccine study group. Successful co-administration of a human rotavirus and oral polio vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine.2009; 27:133-339
35. Bishop RF, Davidson GP, Holmes IH, and Ruck BJ. Virus particles in epithelium cells of duodenal mucosa from children with viral gastroenteritis. Lancet. 1973; 2: 1281-83
36. Parashar UD, Gibson JC, Bresee JS, and Glass RI. Rotavirus and Severe Childhood Diarrhea. Emerg Infect Dis. 2006; 12: 304-6
37. Department of Health Services, Ministry of Health, Nepal. Annual Report (2006/2007). Kathmandu: Department of Health Services, Ministry of Health, Nepal; 2007.p. 68-75.